sb 203580 has been researched along with thimerosal in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (thimerosal) | Trials (thimerosal) | Recent Studies (post-2010) (thimerosal) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 1,310 | 28 | 210 |
| Protein | Taxonomy | sb 203580 (IC50) | thimerosal (IC50) |
|---|---|---|---|
| toll-like receptor 9 | Homo sapiens (human) | 6.339 | |
| caspase recruitment domain family, member 15 | Homo sapiens (human) | 1.402 | |
| receptor-interacting serine/threonine-protein kinase 2 isoform 1 | Homo sapiens (human) | 1.402 | |
| large T antigen | Betapolyomavirus macacae | 32.72 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, PM; Chen, WC; Chou, CT; Chu, ST; Fang, YC; Huang, CC; Huang, CJ; Jan, CR; Liu, SI; Lu, YC; Wang, BW; Wang, JL | 1 |
1 other study(ies) available for sb 203580 and thimerosal
| Article | Year |
|---|---|
Thimerosal-induced apoptosis in human SCM1 gastric cancer cells: activation of p38 MAP kinase and caspase-3 pathways without involvement of [Ca2+]i elevation.
Topics: Anthracenes; Apoptosis; Calcium Signaling; Caspase 3; Cell Line, Tumor; Cell Survival; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Preservatives, Pharmaceutical; Protein Kinase Inhibitors; Pyridines; Stomach Neoplasms; Thimerosal; Time Factors | 2007 |